Cargando…

Stakeholder Views on Active Cascade Screening for Familial Hypercholesterolemia

In familial hypercholesterolemia (FH), carriers profit from presymptomatic diagnosis and early treatment. Due to the autosomal dominant pattern of inheritance, first degree relatives of patients are at 50% risk. A program to identify healthy relatives at risk of premature cardiovascular problems, fu...

Descripción completa

Detalles Bibliográficos
Autores principales:	van El, Carla G., Baccolini, Valentina, Piko, Peter, Cornel, Martina C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163326/ https://www.ncbi.nlm.nih.gov/pubmed/30200297 http://dx.doi.org/10.3390/healthcare6030108

Ejemplares similares

Cascade Screening for Familial Hypercholesterolemia (FH)
por: Ned, Renée M., et al.
Publicado: (2011)

Genetic variations in familial hypercholesterolemia and cascade screening in East Asians
por: Chan, Melody Lok‐Yi, et al.
Publicado: (2018)

CASCADE screening and registry of familial hypercholesterolemia in Iran: Rationale and design
por: Vaseghi, Golnaz, et al.
Publicado: (2019)

Predictors of Family Enrollment in a Genetic Cascade Screening Program for Familial Hypercholesterolemia
por: Silva, Pãmela Rodrigues de Souza, et al.
Publicado: (2018)

Cascade Screening and Treatment Initiation in Young Adults with Heterozygous Familial Hypercholesterolemia
por: Peterson, Amy L., et al.
Publicado: (2021)

Predictors of Family Recruitment in a Program of Genetic Cascade Screening for Familial Hypercholesterolemia
por: Izar, Maria Cristina de Oliveira, et al.
Publicado: (2018)

Cascade Screening in Familial Hypercholesterolemia: Achieving Buy-In and Turning Patients Into Partners
por: Khoury, Michael
Publicado: (2023)

Phenotypic vs. genetic cascade screening for familial hypercholesterolemia: A case report
por: Blokhina, Anastasia V., et al.
Publicado: (2022)

Screening for Familial Hypercholesterolemia in Children: What Can We Learn From Adult Screening Programs?
por: Henneman, Lidewij, et al.
Publicado: (2015)

Developing and Optimizing Innovative Tools to Address Familial Hypercholesterolemia Underdiagnosis: Identification Methods, Patient Activation, and Cascade Testing for Familial Hypercholesterolemia
por: Campbell-Salome, Gemme, et al.
Publicado: (2021)

Long‐Term Cardiovascular Risk in Heterozygous Familial Hypercholesterolemia Relatives Identified by Cascade Screening
por: Kjærgaard, Kasper Aalbæk, et al.
Publicado: (2017)

Genetic Spectrum and Cascade Screening of Familial Hypercholesterolemia in Routine Clinical Setting in Hong Kong
por: Yip, Man-Kwan, et al.
Publicado: (2023)

Familial Hypercholesterolemia: A Systematic Review of Guidelines on Genetic Testing and Patient Management
por: Migliara, Giuseppe, et al.
Publicado: (2017)

Recall by genotype and cascade screening for familial hypercholesterolemia in a population-based biobank from Estonia
por: Alver, Maris, et al.
Publicado: (2018)

Premature Coronary Artery Disease and Familial Hypercholesterolemia: Need for Early Diagnosis and Cascade Screening in the Indian Population
por: Setia, N., et al.
Publicado: (2012)

A proof-of-concept study of cascade screening for Familial Hypercholesterolemia in the US, adapted from the Dutch model
por: McGowan, Mary P., et al.
Publicado: (2021)

Successful Treatment of Homozygous Familial Hypercholesterolemia Using Cascade Filtration Plasmapheresis
por: Kardaş1, Fatih, et al.
Publicado: (2012)

Design of a Controlled Trial of Cascade Screening for Hypercholesterolemia: The (CASH) Study
por: Kullo, Iftikhar J., et al.
Publicado: (2018)

Motivating cascade testing for familial hypercholesterolemia: applying the extended parallel process model for clinician communication
por: Campbell-Salome, Gemme, et al.
Publicado: (2022)

Autosomal Dominant Hypercholesterolemia: Needs for Early Diagnosis and Cascade Screening in the Tunisian Population
por: Jelassi, Awatef, et al.
Publicado: (2013)

Cascade screening for familial hypercholesterolemia-identification of the C308Y mutation in multiple family members and relatives for the first time in mainland China
por: Jin, Weirong, et al.
Publicado: (2019)

Identifying familial hypercholesterolemia in an early onset ischemic cerebrovascular disease patient and the cascade screening in the pedigree: a case report
por: Yuan, Yuan, et al.
Publicado: (2021)

Acceptability, Appropriateness, and Feasibility of Automated Screening Approaches and Family Communication Methods for Identification of Familial Hypercholesterolemia: Stakeholder Engagement Results from the IMPACT-FH Study
por: Jones, Laney K., et al.
Publicado: (2021)

Dynamics of reproductive genetic technologies: Perspectives of professional stakeholders
por: van Dijke, Ivy, et al.
Publicado: (2022)

Newborn screening for pompe disease? a qualitative study exploring professional views
por: van El, Carla G, et al.
Publicado: (2014)

Genetics, Screening, and Treatment of Familial Hypercholesterolemia: Experience Gained From the Implementation of the Vietnam Familial Hypercholesterolemia Registry
por: Truong, Thanh-Huong, et al.
Publicado: (2020)

Genetic screening for homozygous and heterozygous familial hypercholesterolemia
por: Izar, Maria C, et al.
Publicado: (2010)

Finding Importance for Universal Screening of Familial Hypercholesterolemia
por: Yokoyama, Shinji
Publicado: (2022)

Contemporary Homozygous Familial Hypercholesterolemia in the United States: Insights From the CASCADE FH Registry
por: Cuchel, Marina, et al.
Publicado: (2023)

Optimizing communication strategies and designing a comprehensive program to facilitate cascade testing for familial hypercholesterolemia
por: Campbell-Salome, Gemme, et al.
Publicado: (2023)

Web-Based Tool (FH Family Share) to Increase Uptake of Cascade Testing for Familial Hypercholesterolemia: Development and Evaluation
por: Bangash, Hana, et al.
Publicado: (2022)

Designing implementation strategies to improve identification, cascade testing, and management of families with familial hypercholesterolemia: An intervention mapping approach
por: Jones, Laney K., et al.
Publicado: (2023)

Cost-effectiveness of cascade genetic testing for familial hypercholesterolemia in the United States: A simulation analysis
por: Jackson, Candace L., et al.
Publicado: (2021)

Familial Hypercholesterolemia and Elevated Lipoprotein(a): Cascade Testing and Other Implications for Contextual Models of Care
por: Loh, Wann Jia, et al.
Publicado: (2022)

Correction to: Contemporary Homozygous Familial Hypercholesterolemia in the United States: Insights from the CASCADE FH Registry
Publicado: (2023)

Familial Hypercholesterolemia
por: Baruah, Dibya Kumar
Publicado: (2021)

Universal Screening for Familial Hypercholesterolemia in Children in Kagawa, Japan
por: Matsunaga, Keiji, et al.
Publicado: (2022)

Genetically confirmed familial hypercholesterolemia in outpatients with hypercholesterolemia
por: Wang, Xu, et al.
Publicado: (2018)

Parents’ views of genetic testing and treatment of familial hypercholesterolemia in children: a qualitative study
por: Keenan, Karen Forrest, et al.
Publicado: (2018)

Expanding Neonatal Bloodspot Screening: A Multi-Stakeholder Perspective
por: van Dijk, Tessa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r0oidg167sc20j41605jt0ork2